2017-09-18T15:57:45-05:00 2016-12-31 Grant Thornton LLP 100 E Wisconsin Ave Milwaukee WI 53202 990 2016-01-01 390807235 BloodCenter of Wisconsin Inc % PAUL MATSON BLOO 4149335000 PO Box 2178 638 North 18th St Milwaukee WI 532012178 MAUREEN KWIECINSKI ASST CORP SECRETARY 4149335000 2017-09-14 true Michelle L Weber P00556798 4142898200 38.84.128.189 39529020172615000003 2017-09-18 P 7679050E6FFD33370EE8F5FB1864EBFE89AF94B5 DBB5A1BB300CE7347E9A562499B28AD7099757F8 2016 2021-01-29 14:40:06Z Christohper Miskel 638 N 18th Street Milwaukee WI 532332121 219899828 false X WWW.BCW.EDU X 1947 WI RECRUITS BLOOD, STEM CELLS, ORGAN, TISSUE PROVIDES BLOOD, DIAGNOSTIC LAB TESTING, CLINICAL SERVICES, & SPECIALTY PHARMACEUTICALS. CONDUCTS RESEARCH. STRIVES TO PROTECT PUBLIC SAFETY. 16 15 1134 343 0 20381758 22122317 139398787 139695965 923120 1122914 337531 32847 161041196 162974043 3361749 2285244 0 0 71389030 76922259 0 0 0 78215269 75965640 152966048 155173143 8075148 7800900 141088614 149956733 45658320 45625862 95430294 104330871 X RECRUITS BLOOD, STEM CELLS, ORGAN AND TISSUE DONATIONS. PROVIDES BLOOD, DIAGNOSTIC LAB TESTING, CLINICAL SERVICES & SPECIALTY PHARMACEUTICALS. CONDUCTS RESEARCH. STRIVES TO PROTECT PUBLIC SAFETY. false false 44696465 30720 56586587 BLOODCENTER OF WISCONSIN, INC. FULFILLS ITS TAX-EXEMPT PURPOSE BY RECRUITING VOLUNTEER BLOOD DONORS, COLLECTING, PROCESSING AND DISTRIBUTING BLOOD AND BLOOD COMPONENTS TO PROVIDE A SAFE AND STABLE SOURCE FOR CUSTOMERS AT THE 56 HOSPITALS AND OTHER BLOOD CENTERS WE SUPPLY. IN THE YEAR ENDED 2016, OVER 177,325 DONORS COLLECTED OVER 206,215 UNITS OF BLOOD TO PATIENTS IN NEED. 23971914 1748224 0 In the interconnected world of science and medicine research is critical. BloodCenter of Wisconsins research, part of our vision since inception in 1947, spans basic, translational and clinical research that focuses on blood and blood disorders. Our research discoveries make tangible contributions to the care of patients. 23147436 95300 26367219 BLOODCENTER OF WISCONSIN, INC. (BCW) OPERATES THE COMPREHENSIVE CENTER FOR BLEEDING DISORDERS (CCBD), UNDER A FEDERAL SUBAWARD AGREEMENT OF THE SOCIAL SECURITY ACT. CCBD PROVIDES CRITICAL SERVICES TO BLEEDING & CLOTTING DISORDER PATIENTS & THEIR FAMILIES. AS A COVERED ENTITY UNDER THE FEDERAL 340B DRUG DISCOUNT PROGRAM, BCW IS ELIGIBLE TO ACCESS CERTAIN PHARMACEUTICALS AT DISCOUNTED PRICING. PHARMACEUTICAL NET INCOME IS PROGRAM INCOME & FUNDS ARE RESTRICTED TO ACTIVITIES & EXPENDITURES THAT FURTHER ELIGIBLE PROJECTS & PROGRAM OBJECTIVES, INCLUDING PATIENT CARE, EDUCATION, SUPPORT SERVICES, APPROVED GRANT RESEARCH & OTHER COSTS. 22660415 0 34888633 DIAGNOSTIC LABRATORY TESTING 11274739 45000 13635746 ORGAN AND TISSUE DONATIONS 7949594 366000 8255091 MEDICAL SERVICES 41884748 411000 56779470 133700563 true true false true false false false false false true true false false false true true false true false false true false false false false false false true false true true false false false false false false false false false false false false false false false true false false false true 170 0 true 1134 true false false false false false false false false false false X 16 15 true false true false true true true true true false false true true true true true true true true false WI X X PAUL MATSON 4149376349 638 N 18TH STREET Milwaukee WI 532332121 X Jacquelyn Fredrick President & CEO 15.0 40.0 X X 1005020 0 44004 Gilbert White MD Ex VP Res & Dir BRI- thru 9/16 53.0 2.0 X X 661854 0 47330 James M Rauh Chair - thru 9/2016; treasurer 1.0 3.0 X X 0 0 0 Dale Kent Vice Chair - thru 9/2016; dir. 1.0 2.0 X X 0 0 0 John D Oliverio Secretary 1.0 2.0 X X 0 0 0 Johan Segerdahl Treasurer - thru 9/2016 1.0 2.0 X X 0 0 0 Andy Anderson MD Board Member - thru 9/2016 1.0 2.0 X 0 0 0 Richard Anderson MD Board Member - Thru 9/2016 1.0 1.0 X 0 0 0 Cathy Buck Board Member - as of 10/2016 1.0 2.0 X 0 0 0 Susan Edwards Board Member - thru 9/2016 1.0 1.0 X 0 0 0 Richard J Fotsch Board Member - As of 10/2016 1.0 2.0 X 0 0 0 Fred Geilfuss Board Member - As of 10/2016 1.0 2.0 X 0 0 0 Marc Gorelick MD Board Member - thru 9/2016 1.0 1.0 X 0 0 0 Emery Harlan Board Member - thru 9/2016 1.0 2.0 X 0 0 0 Thomas Hauske JR Board Member - As of 10/2016 1.0 2.0 X 0 0 0 Gregory Larkin Board Member - As of 10/2016 1.0 3.0 X 0 0 0 Robert H Manegold Board Member 1.0 3.0 X 0 0 0 Jeffrey S McDonald Board Member 1.0 2.0 X 0 0 0 John Perras Board Member - As of 10/2016 1.0 3.0 X 0 0 0 Larry Rambo Board Member - thru 9/2016 1.0 2.0 X 0 0 0 Corey B Rubenstein Board Member - Thru 9/2016 1.0 2.0 X 0 0 0 Paul Skalecki Board Member - thru 9/2016 1.0 2.0 X 0 0 0 Peggy Troy Board Member - Thru 9/2016 1.0 1.0 X 0 0 0 Mitchell G Watt Board Member - As of 10/2016 1.0 3.0 X 0 0 0 L Alan Whaley Board Member - As of 10/2016 1.0 3.0 X 0 0 0 E Randall Wright Board Member - As of 10/2016 1.0 3.0 X 0 0 0 Peter Ziegler Board Member 1.0 3.0 X 0 0 0 Thomas Abshire MD SR VP MSI & CMO 55.0 0.0 X 601284 0 40691 Ilke Panzer Sr VP Diagnostic Labs 55.0 0.0 X 480267 0 58472 James Mitchell Sr VP Blood Services 39.0 16.0 X 265046 113591 44060 Anthony Watkins Sr VP & CFO 38.0 17.0 X 281455 120621 44832 Maureen Kwiecinski Asst Corporate Secretary 27.0 28.0 X 187187 187187 30879 Lynne Briggs VP Information Svcs & CIO 36.0 19.0 X 179688 96755 42636 Sandi Lemons VP Human Resource Services 28.0 27.0 X 137627 132858 38875 Margaret McElligott VP Quality Services 34.0 21.0 X 150267 90159 42955 Peter Newman PHD VP Research & Assoc Dir BRI 55.0 0.0 X 404727 0 54043 Jerome Gottschall MD VP Medical Services 55.0 0.0 X 341534 0 50977 Mehraboon Irani MD Medical Dir of therapeutic svs 55.0 0.0 X 325418 0 37631 Kenneth Friedman MD Medical Director 55.0 0.0 X 300423 0 48881 Robert R Montgomery MD Senior Investigator 55.0 0.0 X 300214 0 39639 5622011 741171 665905 94 false true false MEDICAL COLLEGE OF WISCONSIN 8701 WATERTOWN PLANK RoaD MILWAUKEE WI 53226 MEDICAL SERVICES 1636065 BIOMEDICAL RESOURCE CENTER 8701 WATERTOWN PLANK ROAD MILWAUKEE WI 53226 MEDICAL RESEARCH 835489 FROEDTERT HEALTH 9200 W WISCONSIN AVENUE MILWAUKEE WI 53226 MEDICAL SERVICES 743933 QUEEN'S UNIVERSITY 207 STUART STREET KINGSTON ONTARIO CA K7L 3NG MEDICAL RESEARCH 622544 AURORA HEALTH CARE INC PO BOX 341100 ITASCA IL 53234 MEDICAL SERVICES 616721 48 7249858 11842122 3030337 22122317 BLOOD SERVICES 621500 56586587 56586587 DIAGNOSTIC LABORATORIES 621500 34888633 34888633 PHARMACY 621500 26367219 26367219 ORGAN AND TISSUE DONATION 621500 13635746 13635746 MEDICAL SERVICES 621500 8217780 8217780 139695965 1133577 1133577 0 0 30000 34464 -4464 0 -4464 -4464 56762459 118199 56506232 385089 256227 -266890 -10663 -10663 0 0 0 0 0 0 0 0 0 SUPPORT FOR RADIATION ASSESSMENT 561000 20501 20501 PROCEEDS FROM SALE OF PROCEDURES 561000 15000 15000 MISCELLENEOUS 900099 1810 1810 37311 162974043 139733276 1118450 2285244 2285244 0 0 0 4419002 2312595 2106407 0 57389298 48261048 9128250 3969881 3416143 553738 7231479 6128605 1102874 3912599 3295845 616754 0 176387 11253 165134 262113 262113 0 0 186694 186694 12924853 11452086 1472767 550512 373149 177363 1031294 850028 181266 1855791 946778 909013 27605 27605 4520357 2967200 1553157 742126 704503 37623 0 1716650 1471382 245268 85402 85402 0 4892587 3023822 1868765 417064 53519 363545 PHARMACEUTICAL PRODUCTS 22711863 22711863 0 MEDICAL LAB SUPPLIES 21180981 21180146 835 COST OF IMPORTS 950561 950561 DUES & MEMBERSHIPS 314143 137397 176746 1418657 1139791 278866 155173143 133700563 21472580 0 193000 200000 26279204 30256156 0 0 25063158 24817855 0 0 0 0 0 0 6599963 5601744 1341207 1309631 103894995 64835691 40092299 39059304 41491533 48683792 0 0 0 0 0 0 28250 28251 141088614 149956733 29850289 29751132 0 0 0 0 4374824 3802023 0 0 0 0 0 0 0 0 11433207 12072707 45658320 45625862 X 95430294 104330871 0 0 0 0 95430294 104330871 141088614 149956733 X 7800900 1659866 -560189 X false true X true true true X 16594248 17934403 19235934 20381758 22122317 96268660 0 0 16594248 17934403 19235934 20381758 22122317 96268660 29449803 66818857 769884 707545 604827 677004 1163577 3922837 0 0 0 0 0 0 0 0 0 0 0 0 100191497 679267425 0.66691 0.68371 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED false false false false false false false false true 911 911 false OTHER ACTIVITIES PART II-B, LINE II $911 OF THE DUES PAID TO THE ASSOCIATION OF ORGAN PROCUREMENT ORGANIZATIONS HAS BEEN ALLOCATED TO LOBBYING. 72401518 793676 7045041 3800429 76439806 81135521 471114 -5788954 3416163 72401518 81439963 1466377 1316637 2937763 149693 81135521 74174152 362882 9536701 2460513 173259 81439963 65750649 478855 10026143 2081495 74174152 1.00000 false true true 0 2705072 2705072 0 61537204 34602042 26935162 0 718833 544378 174455 0 27875262 24714456 3160806 0 11058624 4974815 6083809 39059304 0 LONG-TERM PENSION OBLIGATIONS 12072707 12072707 X 164375074 1659866 -560189 1099677 163275397 -301354 -301354 162974043 155474497 301354 301354 155173143 155173143 Part V ENDOWNMENT FUNDS THE BOARD DESIGNATED ENDOWMENT FUNDS (HELD BY BLOODCENTER RESEARCH FOUNDATION) ("BCRF") ARE DESIGNATED BY THE BOARD AS ENDOWMENT FUNDS TO ENSURE THE CONTINUING AVAILABILITY OF FUNDS FOR RESEARCH PURPOSES. THE FILING ORGANIZATION IS ONE OF FOUR SUPPORTED ORGANIZATIONS OF BCRF THAT ARE BENEFICIARIES OF THE ENDOWMENT. PART X INCOME TAXES Versiti, BloodCenter, Heartland, Michigan, Indiana and the Foundation have all received tax determination letters confirming that the organizations qualify as tax-exempt organizations under section 501(c)(3) of the Internal Revenue Code (IRC). The Organization follows guidance that clarifies the accounting for uncertainty in tax positions taken or expected to be taken in a tax return, including issues relating to financial statement recognition and measurement. This guidance provides that the tax effects from an uncertain tax position can only be recognized in the financial statements if the position is more likely than not to be sustained if the position were to be challenged by a taxing authority. The assessment of the tax position is based solely on the technical merits of the position, without regard to the likelihood that the tax position may be challenged. Versiti, BloodCenter, Heartland, Michigan, Indiana and the Foundation are exempt from federal income tax under IRC section 501(c)(3), though they are subject to tax on income unrelated to their exempt purposes, unless that income is otherwise excluded by the IRC. The Organization has processes presently in place to ensure the maintenance of its tax-exempt status; to identify and report unrelated income; to determine its filing and tax obligations in jurisdictions for which it has nexus; and to identify and evaluate other matters that may be considered tax positions. BloodCenter and the Foundation have filed federal and state of Wisconsin income tax returns to report unrelated business income through 2009 and are no longer subject to tax authority examinations for years prior to 2010 under the federal and state statute. Management has determined that there is no unrelated business income to report for BloodCenter or the Foundation for 2010 through 2016, and income tax returns are not required to be filed. Therefore, as the statute of limitations will remain open for returns not filed, tax years 2010 through 2016, will remain open to audit for both federal and state purposes. The Organization has determined that there are no material uncertain tax positions that require recognition or disclosure in the consolidated financial statements. The Organization recognizes, if necessary, interest and penalties related to unrecognized tax benefits in the provision for income taxes. There were no interest or penalties related to income taxes that have been accrued or recognized as of and for the years ended December 31, 2016 and 2015. Part XI, Line 2d Reconciliation of Revenue Additional Minimum Pension Benefit $(560,189) Part XI, Line 4b Rental Activity Expenses $(34,464) Loss on Asset Sale (266,890) --------- Total (301,354) Part XII, Line 2d Reconciliation of Expenses Rental Activity Expenses $34,464 Loss on Asset Sale 266,890 --------- Total 301,354 true North America Program Services Research Grant 622544 622544 622544 false false false false false false true BLOODCENTER RESEARCH FOUNDATION INC 638 NORTH 18TH STREET MILWAUKEE WI 53233 391372542 501(c)(3) 2126224 RESEARCH GREAT LAKES HEMOPHILIA FOUNDATION INC 638 NORTH 18TH STREET MILWAUKEE WI 53233 237367636 501(C)(3) 99950 PATIENT FINANCIAL AS NATIONAL BLOOD FOUNDATION 8101 GLENBROOK ROAD BETHESDA MD 20814 362384118 501(C)(3) 25000 RESEARCH 3 0 Part I, Line 2 GRANTS BLOODCENTER OF WISCONSIN, INC. CONTINUES TO PROVIDE GRANT FUNDING TO BLOODCENTER RESEARCH FOUNDATION, INC. AND OTHER TAX-EXEMPT ORGANIZATIONS. THESE FUNDS WILL SUPPORT FUTURE BLOOD RESEARCH AND OTHER INITIATIVES TO SERVE MORE PATIENTS AND REDUCE OVERALL COSTS. MONITORING THE INVESTMENT OF THESE FUNDS, THE DISTRIBUTIONS AND WHAT THESE FUNDS ARE USED FOR IS COMPLETED BY LEADERSHIP OF BLOODCENTER OF WISCONSIN, INC. X true true X X X X X false true false false false false false true false Jacquelyn Fredrick President & CEO 597950 0 73294 0 333776 0 41834 0 2170 0 1049024 0 310578 0 Gilbert White MD Ex VP Res & Dir BRI- thru 9/16 487165 0 150953 0 23736 0 32049 0 15281 0 709184 0 0 0 Thomas Abshire MD SR VP MSI & CMO 431752 0 146334 0 23198 0 37021 0 3670 0 641975 0 0 0 Ilke Panzer Sr VP Diagnostic Labs 343068 0 117393 0 19806 0 37764 0 20708 0 538739 0 0 0 James Mitchell Sr VP Blood Services 208840 89503 55092 23611 1114 477 12985 5565 17857 7653 295888 126809 0 0 Anthony Watkins Sr VP & CFO 245248 105105 30069 12885 6138 2631 15661 6711 15722 6738 312838 134070 0 0 Maureen Kwiecinski Asst Corporate Secretary 160756 160755 16845 16845 9586 9587 12804 12804 2635 2636 202626 202627 0 0 Lynne Briggs VP Information Svcs & CIO 163681 88134 14421 7766 1586 855 13670 7361 14042 7563 207400 111679 0 0 Sandi Lemons VP Human Resource Services 125861 121496 11330 10939 436 423 9274 8952 10506 10143 157407 151953 0 0 Margaret McElligott VP Quality Services 125112 75069 11955 7173 13200 7917 15748 9450 11097 6660 177112 106269 0 0 Peter Newman PHD VP Research & Assoc Dir BRI 307551 0 74405 0 22771 0 44643 0 9400 0 458770 0 0 0 Jerome Gottschall MD VP Medical Services 302433 0 16010 0 23091 0 34746 0 16231 0 392511 0 0 0 Mehraboon Irani MD Medical Dir of therapeutic svs 308029 0 14425 0 2964 0 18550 0 19081 0 363049 0 0 0 Kenneth Friedman MD Medical Director 264452 0 14139 0 21832 0 30051 0 18830 0 349304 0 0 0 Robert R Montgomery MD Senior Investigator 269057 0 8624 0 22533 0 22810 0 16829 0 339853 0 0 0 Part I, Line 1a BUSINESS CLUB DUES BLOODCENTER OF WISCONSIN, INC. PROVIDES BUSINESS CLUB MEMBERSHIPS FOR THE FOLLOWING EMPLOYEES: -JACQUELYN FREDRICK -GILBERT WHITE THE CLUB MEMBERSHIPS ARE NOT TREATED AS TAXABLE COMPENSATION. THE EMPLOYEES USE THESE MEMBERSHIPS FOR BUSINESS MEETINGS OFF SITE AND BUSINESS LUNCHES/DINNERS. ANY PERSONAL EXPENSES INCURRED AT THE CLUB ARE PAID FOR DIRECTLY BY THE EMPLOYEES OR THE EMPLOYEES REIMBURSE THE ENTITY FOR PERSONAL EXPENSES. Part I, Line 4b SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN TO ENSURE BLOODCENTER OF WISCONSIN, INC. ACHIEVES ITS MISSION, IT IS ESSENTIAL TO ATTRACT LEADING EXPERTS IN TRANSFUSION MEDICINE, SCIENCE AND BUSINESS BY PAYING COMPETITIVE SALARIES AND BENEFITS. BLOODCENTER OF WISCONSIN, INC. BOARD OF DIRECTORS FOLLOWS NOT-FOR-PROFIT BEST PRACTICES BY HIRING AN INDEPENDENT COMPENSATION CONSULTANT TO ANNUALLY REVIEW THE OVERALL EXECUTIVE COMPENSATION PROGRAMS. JACQUELYN FREDRICK, CEO, PARTICIPATED IN A SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN (SERP). THE AMOUNT DEFERRED DURING 2016 IN SERVICE OF THE SERP PLAN WAS $228,005. THE AMOUNT PAID AND INCLUDED IN SCHEDULE J, PART II, COLUMN B(III) DURING 2016 IN SERVICE OF THE SERP PLAN WAS $310,578, WHICH INCLUDES $310,578 THAT WAS PREVIOUSLY REPORTED AS DEFERRED COMPENSATION ON SCHEDULE J, PART II, COLUMN C. Part I, Line 7 Non-Fixed Payments Incentive payout opportunities, based on percentage of base pay rate, are available to certain employees of the filing organization. While levels of the incentive payout opportunity are fixed and determined percentages of base compensation; the incentive payout is subject to the review of accomplishments/ objectives and the ultimate determination of incentive compensation is subject to President / CEO and Executive Committee of the Board approval. A WI HEALTH EDUCATIONAL FACILITIES AUTHORITY (1994A) 391337855 2009-08-19 7145000 proceeds used to currently refund false false false A 3310000 0 7145000 0 0 0 0 0 0 0 0 0 1989 true false true true A 0 A false false false true true false 0 false 0 false false A true Sch K Part IV Line 2c Part IV, Line 2C Rebate Calculation A REBATE CALCULATION WAS LAST PERFORMED ON 7/29/2011 FOR THE WHEFA 1994A BOND. Part III, Line 4d Other Program Services BloodCenter of Wisconsin, Inc. fulfills its tax-exempt purpose in three ways: A. Blood research institute conducts research in vascular biology, immunobiology, transfusion medicine, hemostasis and stem cell biology. B. Organ and Tissue Donation combines procurement services and education to enhance the lives of patients and provides guidance to the families of potential donors. C. Medical Sciences Institute provides medical services including consultation with hospitals we serve, special patient services for patients with unique blood disorders including providing community education programs for medical professionals through routine lecture series and the specialist in blood banking programs. PART VI, SECTION A, LINE 2 Business Relationship DALE KENT AND PETER ZIEGLER HAVE A BUSINESS RELATIONSHIP. RICHARD GALLAGHER AND JOHAN SEGERDAHL HAVE A BUSINESS RELATIONSHIP. JOHN OLIVERIO AND CATHY BUCK HAVE A BUSINESS RELATIONSHIP. PART VI, SECTION A, Line 4 Significant Changes to Governing Documents In 2016, BloodCenter of Wisconsin, Inc. amended its bylaws for the following changes: - The number and composition of the Board of directors. The board of Directors shall consist of not less than three (3), nor more than twenty-five (25) Directors, and shall be comprised of the then-serving Directors of the Corporate Member ("Versiti"). - Committees: The Board of Directors, by resolution dated September 21, 2016, delegated oversight of the Corporation's investment and finance function to the Versiti Investment & Finance Committee. The Board of Directors, by resolution dated September 21, 2016, delegated oversight of the governance function to the Versiti Governance Committee. Part VI, Section A, Line 6 Members or Stockholders VERSITI, Inc. IS THE SOLE CORPORATE MEMBER. Part VI, SECTION A, Lines 7a and 7b Member or Stockholder Powers VERSITI, Inc. HAS RESERVE POWERS; INCLUDING THE ABILITY TO ELECT A MAJORITY OF DIRECTORS. PART VI, SECTION B, LINE 11B Form 990 Review BLOODCENTER OF WISCONSIN UTILIZES GRANT THORNTON LLP TO COMPLETE THE IRS FORM 990 AND RELATED SCHEDULES. FOLLOWING COMPLETION, THEY ARE REVIEWED BY THE CONTROLLER, SR. VICE PRESIDENT AND CFO AND THE PRESIDENT AND CEO. THE DRAFT FORMS ARE THEN REVIEWED BY THE COMPLIANCE AND AUDIT COMMITTEE PRIOR TO SUBMISSION TO THE IRS. THE FULL BOARD IS PROVIDED A COPY OF THE FORM 990 PRIOR TO FILING. PART VI, SECTION B, LINE 12c Conflict of Interest Policy BLOODCENTER OF WISCONSIN MAINTAINS A WRITTEN CONFLICT OF INTEREST POLICY. ON AN ANNUAL BASIS, CURRENT DIRECTORS AND OFFICERS ARE ASKED TO COMPLETE A DISCLOSURE FORM BASED ON IRS REQUIREMENTS THAT INCLUDES THE FOLLOWING: WHETHER THEY HAVE ANY DIRECT OR INDIRECT RELATIONSHIP EITHER THROUGH BUSINESS OR FAMILY MEMBER WITH BLOODCENTER OF WISCONSIN. WHETHER THEY RECEIVED COMPENSATION FROM ANY ORGANIZATION THAT SHARES COMMON OWNERSHIP OR CONTROL WITH BLOODCENTER OF WISCONSIN. WHETHER THEY HAVE SERVED AS AN OFFICER, DIRECTOR, KEY EMPLOYEE, PARTNER OR MEMBER OF AN ENTITY (OR SHAREHOLDER OF A PROFESSIONAL CORPORATION) DOING BUSINESS WITH BLOODCENTER OF WISCONSIN. THESE ANSWERS ARE ACCUMULATED, SUMMARIZED AND EVALUATED BY MANAGEMENT TO DETERMINE IF ANY CONFLICTS EXIST. IDENTIFIED CONFLICTS ARE ADDRESSED IN ACCORDANCE WITH THE WRITTEN POLICY. Part VI, SECTION B, LINES 15A AND 15B Compensation Process Versiti and its affiliated blood centers greatly value the generous contributions of the individuals and organizations that support our mission within the community we serve. In order to ensure proper stewardship of our charitable resources, Versiti and its affiliates follow a formalized process to confirm that compensation provided to our executive leadership team is fair, reasonable, and not excessive when compared to other executives. This process also helps us ensure that our compensation program supports the retention of experienced, highly-qualified executives who are committed to our mission. The Compensation Committee of the Versiti Board of Directors, acting in its capacity as the Compensation Committee, sets and monitors the compensation philosophy for Versiti and the related entities that it supports, including BloodCenter of Wisconsin (BCW). Other than the Versiti President and Chief Executive Officer, the Compensation Committee does not include members of management and is comprised entirely of individuals who do not have a conflict of interest with respect to Versiti compensation arrangements. The Versiti President and Chief Executive Officer recuses her/himself from all discussions and approvals related to her/his compensation. The Versiti Compensation Committee reviews executive compensation arrangements to ensure such arrangements are fair, reasonable, and not excessive when compared to similarly-situated executives. Executive compensation arrangements are reviewed for reasonableness and approved by the Compensation Committee annually in accordance with the Versiti Reasonableness Review Policy. In order to assess the reasonableness of executive compensation arrangements, the Compensation Committee obtains and reviews appropriate comparability data collected by the human resource department and a qualified independent compensation consultant. The Compensation Committee engages a qualified independent compensation consultant annually. The independent consultant performs an analysis of compensation levels at regional and national organizations of comparable size, scope and structure; and provides the Committee with comprehensive data on the availability of similar services within the geographic area, compensation surveys, written offers from similar institutions, and other information relevant to comparability of compensation. The Compensation Committee's review, recommendations and approvals are documented concurrently in the Committee minutes, which are subsequently reviewed and approved by the Compensation Committee as reasonable, accurate and complete. A copy of the Compensation Committee's minutes is also provided to the Versiti Board of Directors. Versiti and BCW have incentive programs for executives, directors, management, investigators and staff described in detailed written policies approved by the Compensation Committee annually. Evaluation and compensation review -CEO - Each year, the Executive/Compensation Committee evaluates the CEO's performance against established objectives, determines incentive payment and merit increase based upon performance and market data provided by the third party compensation consultant, and works with the CEO to establish objectives for the next year. -Executives - Each year, the Versiti/BCW CEO reviews the performance of each executive and the achievement of their individual goals and objectives. The Versiti/BCW CEO presents his/her recommendations to the Compensation Committee, which reviews and approves recommended compensation ranges, and approves final salary and incentive payments. Executives are positioned within the appropriate salary range based upon the: -executive's knowledge, competencies, and experience, -performance of the executive's areas of responsibility, -the executive's contribution to overall performance, -the importance of retaining the executive, -internal equity considerations, -the financial resources available, and -executive base salary increases provided in the competitive market. Part VI, SECTION C, LINE 19 Organization's Documents Open to the Public THE ORGANIZATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST TO THE PUBLIC. VIEWING IS DONE ON THE ORGANIZATION'S PREMISES. Part VII Average Hours The hours listed on Form 990, Part VII are representative of an average for the officers and executive team. Each individual person's weekly tally may be greater or lesser per week based on their individual roles and responsibilities within the filing organization and related parties. The salary presented for the President and CEO is reflective of total salary compensation for services to the filing organization and related affiliates. Part IX, Line 9 OTHER CHANGES IN NET ASSETS PENSION ADJUSTMENT (506,189) BloodCenter Research Foundation Inc PO Box 2178 638 North 18th Stree Milwaukee WI 53201 391372542 Supporting WI 501(c)(3) 12B Versiti false Versiti Inc PO Box 2178 638 North 18th Stree Milwaukee WI 53201 454675354 Supporting WI 501(c)(3) 12B NA false Aurora Area Blood Bank dba Heartland 1200 N Highland Avenue Aurora IL 60506 364179758 Blood IL 501(c)(3) 10 Versiti false Michigan Blood PO Box 1704 Grand Rapids MI 49501 381550001 Blood MI 501(c)(3) 10 Versiti false Central Indiana Regional Blood Center 3450 North Meridian Street Indianapolis IN 46208 350991629 Blood IN 501(c)(3) 10 Versiti false false true true false false false false false false false false true true true true false true false false